Evaluating Adjuvant Radiation Therapy Survival Benefit in Early-Stage HER2-Positive Invasive Breast Cancer Following Breast-Conserving Surgery: A National Cohort Aligned with NRG-BR008 HERO Trial.
Saved in:
| Title: | Evaluating Adjuvant Radiation Therapy Survival Benefit in Early-Stage HER2-Positive Invasive Breast Cancer Following Breast-Conserving Surgery: A National Cohort Aligned with NRG-BR008 HERO Trial. |
|---|---|
| Authors: | Cummock JS; Department of Medical Sciences, Texas A&M University Naresh K. Vashisht College of Medicine, Bryan, TX 77807, USA., Haider AJ; Department of Radiation Oncology, University of Texas Medical Branch, Galveston, TX 77550, USA., Kazmi M; University of North Texas Health Science Center, Texas College of Osteopathic Medicine, Fort Worth, TX 76137, USA., Haque WM; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX 77030, USA., Farach AM; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX 77030, USA., Butler EB; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX 77030, USA., Teh BS; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX 77030, USA. |
| Source: | Cancers [Cancers (Basel)] 2026 Jan 23; Vol. 18 (3). Date of Electronic Publication: 2026 Jan 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
